MabVax Therapeutics Holdings Inc (MBVX) - Financial and Strategic SWOT Analysis Review

August 2018 | 45 pages | ID: M56B1F51EBEEN
GlobalData

Abstracts

MabVax Therapeutics Holdings Inc (MBVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Key manufacturing facilities – A list of key manufacturing facilities of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

MabVax Therapeutics Holdings Inc (MabVax Therapeutics) formerly known as Telik, Inc. is a clinical-stage biotechnology company that focuses on development of pipeline of human monoclonal antibody products for diagnosis and treatment of cancer. The company's research and development activities are focused on advancing its clinical advanced drug candidates, under the antibody and vaccine programs. The pipeline product candidates include HuMab-5B1, MVT-5873, MVT-2163 and MVT-1075. The company’s vaccine programs candidates for bivalent vaccine, trivalent vaccine, pentavalent vaccine and multiple vaccines. The company has partnerships with academic institutions and also with pharmaceutical and biotechnology companies. MabVax Therapeutics is headquartered in San Diego, California, the US.

MabVax Therapeutics Holdings Inc Key Recent Developments

Aug 03,2018: Delaware Court of Chancery sets hearing date On petition filed By MabVax Therapeutics
Aug 01,2018: MabVax Therapeutics announces board of director changes
Jul 27,2018: MabVax Therapeutics Files Delaware Petition
Jul 05,2018: MabVax Therapeutics Receives Nasdaq Delist Determination
Jun 27,2018: MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

MabVax Therapeutics Holdings Inc - Key Facts
MabVax Therapeutics Holdings Inc - Key Employees
MabVax Therapeutics Holdings Inc - Key Employee Biographies
MabVax Therapeutics Holdings Inc - Major Products and Services
MabVax Therapeutics Holdings Inc - History
MabVax Therapeutics Holdings Inc - Company Statement
MabVax Therapeutics Holdings Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
MabVax Therapeutics Holdings Inc - Business Description
MabVax Therapeutics Holdings Inc - SWOT Analysis
SWOT Analysis - Overview
MabVax Therapeutics Holdings Inc - Strengths
MabVax Therapeutics Holdings Inc - Weaknesses
MabVax Therapeutics Holdings Inc - Opportunities
MabVax Therapeutics Holdings Inc - Threats
MabVax Therapeutics Holdings Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
MabVax Therapeutics Holdings Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Aug 03, 2018: Delaware Court of Chancery sets hearing date On petition filed By MabVax Therapeutics
Aug 01, 2018: MabVax Therapeutics announces board of director changes
Jul 27, 2018: MabVax Therapeutics Files Delaware Petition
Jul 05, 2018: MabVax Therapeutics Receives Nasdaq Delist Determination
Jun 27, 2018: MabVax Therapeutics Receives Superseding Letter Related to the Late Filing of Form 10-Q
May 03, 2018: MabVax Therapeutics Holdings Announces Private Placement Offering
Apr 13, 2018: MabVax Therapeutics Receives Continued Listing Deficiency Notice for Nasdaq's Minimum Stockholders' Equity Requirements
Apr 02, 2018: MabVax Therapeutics Reports 2017 Operational and Financial Results and 2018 Milestones
Feb 15, 2018: MabVax Therapeutics Schedules Previously Announced 1-for-3 Reverse Stock Split to Regain Compliance with NASDAQ's $1.00 Minimum Bid Price Maintenance Requirement
Jan 16, 2018: MabVax Therapeutics Holdings Provides Business Strategy Update

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

MabVax Therapeutics Holdings Inc, Key Facts
MabVax Therapeutics Holdings Inc, Key Employees
MabVax Therapeutics Holdings Inc, Key Employee Biographies
MabVax Therapeutics Holdings Inc, Major Products and Services
MabVax Therapeutics Holdings Inc, History
MabVax Therapeutics Holdings Inc, Subsidiaries
MabVax Therapeutics Holdings Inc, Key Competitors
MabVax Therapeutics Holdings Inc, Ratios based on current share price
MabVax Therapeutics Holdings Inc, Annual Ratios
MabVax Therapeutics Holdings Inc, Annual Ratios (Cont.1)
MabVax Therapeutics Holdings Inc, Interim Ratios
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
MabVax Therapeutics Holdings Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

MabVax Therapeutics Holdings Inc, Performance Chart (2013 - 2017)
MabVax Therapeutics Holdings Inc, Ratio Charts
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
MabVax Therapeutics Holdings Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018

COMPANIES MENTIONED

Genentech Inc
CTI BioPharma Corp
PaxVax Inc
Onyx Pharmaceuticals Inc